Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGXTER:AJ91 -0.84%71 FCF Margin % is -1.37% as of Dec. 2025. GuruFocus rates XTER:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.52 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, DocCheck AG ranks better than 52.25% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DocCheck AG's Free Cash Flow for the
six
months ended in Dec. 2025 was €-0.39 Mil. DocCheck AG's Revenue for the
six
months ended in Dec. 2025 was €28.77 Mil. Therefore, DocCheck AG's FCF Margin % for the quarter that ended in Dec. 2025 was -1.37%.
The historical rank and industry rank for DocCheck AG's FCF Margin % or its related term are showing as below:
XTER:AJ91'
s FCF Margin % Range Over the Past 10 Years
Min: -0.81 Med: 7.18 Max: 12.89
Current: 4.04
During the past 13 years, the highest FCF Margin % of DocCheck AG was 12.89%. The lowest was -0.81%. And the median was 7.18%.
XTER:AJ91's FCF Margin % is ranked better than 52.25% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.365
vs XTER:AJ91: 4.04
DocCheck AG FCF Margin % Related Terms
DocCheck AG FCF Margin % Historical Data
* Premium members only.
The historical data trend for DocCheck AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:AJ91 vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, DocCheck AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where DocCheck AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (XTER:AJ91) has a FCF Margin % of -1.37% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DocCheck AG and its competitors. According to the industry distribution chart, DocCheck AG ranks #319 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 47.8%.
Is DocCheck AG's FCF Margin % too high?
DocCheck AG's current FCF Margin % is -1.37%. Based on the distribution chart, DocCheck AG ranks #319 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #319 out of 668 companies for FCF Margin %. This puts DocCheck AG in the upper half of its industry. The industry median FCF Margin % is 3.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.37, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DocCheck AG and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current FCF Margin % is -1.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (XTER:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.52, compared to a current price of €11.80 — trading 23.9% above its estimated fair value. The current FCF Margin % is -1.37%. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DocCheck AG (XTER:AJ91), the current FCF Margin % is -1.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (XTER:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.80 is trading 23.9% above its estimated GF Value™ of €9.52.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for XTER:AJ91:
FCF Margin %: -1.37%
GF Value™: €9.52 vs. price of €11.80 (23.9% above fair value)
No single metric tells the full story. See the XTER:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for XTER:AJ91
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:AJ91 has been successfully added to your 
